PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-09
DOI
10.1038/s41598-017-02162-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SphK1 inhibitor potentiates the anti-cancer effect of EGCG on leukaemia cells
- (2016) Shuntaro Tsukamoto et al. BRITISH JOURNAL OF HAEMATOLOGY
- FOXO3 is essential for CD44 expression in pancreatic cancer cells
- (2016) M Kumazoe et al. ONCOGENE
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Double-Blind Placebo-Controlled Study of the Effects of Olprinone, a Specific Phosphodiesterase III Inhibitor, for Preventing Postoperative Atrial Fibrillation in Patients Undergoing Pulmonary Resection for Lung Cancer
- (2015) Takashi Nojiri et al. CHEST
- Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
- (2015) Daniel V.T. Catenacci et al. JOURNAL OF CLINICAL ONCOLOGY
- New insights into pancreatic cancer stem cells
- (2015) Chinthalapally V Rao World Journal of Stem Cells
- Intracellular autofluorescence: a biomarker for epithelial cancer stem cells
- (2014) Irene Miranda-Lorenzo et al. NATURE METHODS
- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- Histological and prognostic importance of CD44+/CD24+/EpCAM+expression in clinical pancreatic cancer
- (2013) Yusuke Ohara et al. CANCER SCIENCE
- DCLK1 Marks a Morphologically Distinct Subpopulation of Cells With Stem Cell Properties in Preinvasive Pancreatic Cancer
- (2013) Jennifer M. Bailey et al. GASTROENTEROLOGY
- How valid are claims for synergy in published clinical studies?
- (2012) A. Ocana et al. ANNALS OF ONCOLOGY
- Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia
- (2012) Tait D. Shanafelt et al. CANCER
- Pancreatic cancer stem cells: Emerging target for designing novel therapy
- (2012) Yiwei Li et al. CANCER LETTERS
- Identification of Pancreatic Cancer Stem Cells and Selective Toxicity of Chemotherapeutic Agents
- (2012) Rama Adikrisna et al. GASTROENTEROLOGY
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- (2012) Aleksandar Sekulic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells
- (2011) Barbara Varnum-Finney et al. JOURNAL OF CLINICAL INVESTIGATION
- The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
- (2011) Can Liu et al. NATURE MEDICINE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Construction and Validation of a Prognostic Index for Patients With Metastatic Pancreatic Adenocarcinoma
- (2011) Chigusa Morizane et al. PANCREAS
- Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-transretinoic acid-induced neutrophil differentiation via death-associated protein kinase 2
- (2010) Adrian Britschgi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Solid-Phase Synthesis of a Combinatorial Methylated (±)-Epigallocatechin Gallate Library and the Growth-Inhibitory Effects of these Compounds on Melanoma B16 Cells
- (2010) Hiroshi Tanaka et al. Chemistry-An Asian Journal
- TGF-β–FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia
- (2010) Kazuhito Naka et al. NATURE
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- Polyphenon E®: a new treatment for external anogenital warts
- (2009) S. Tatti et al. BRITISH JOURNAL OF DERMATOLOGY
- Two populations of endochondral osteoblasts with differential sensitivity to Hedgehog signalling
- (2009) C. L. Hammond et al. DEVELOPMENT
- 67-kDa Laminin Receptor in Human Bile Duct Carcinoma
- (2009) D. Li et al. EUROPEAN SURGICAL RESEARCH
- Phase I Trial of Daily Oral Polyphenon E in Patients With Asymptomatic Rai Stage 0 to II Chronic Lymphocytic Leukemia
- (2009) Tait D. Shanafelt et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple Functions of the 37/67-kd Laminin Receptor Make It a Suitable Target for Novel Cancer Gene Therapy
- (2009) Jonathan Scheiman et al. MOLECULAR THERAPY
- A Temporal Switch from Notch to Wnt Signaling in Muscle Stem Cells Is Necessary for Normal Adult Myogenesis
- (2008) Andrew S. Brack et al. Cell Stem Cell
- Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia
- (2008) L. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started